vs

Side-by-side financial comparison of CVD EQUIPMENT CORP (CVV) and RETRACTABLE TECHNOLOGIES INC (RVP). Click either name above to swap in a different company.

RETRACTABLE TECHNOLOGIES INC is the larger business by last-quarter revenue ($9.4M vs $5.0M, roughly 1.9× CVD EQUIPMENT CORP). RETRACTABLE TECHNOLOGIES INC runs the higher net margin — -24.9% vs -25.6%, a 0.7% gap on every dollar of revenue. On growth, RETRACTABLE TECHNOLOGIES INC posted the faster year-over-year revenue change (4.0% vs -33.2%). Over the past eight quarters, RETRACTABLE TECHNOLOGIES INC's revenue compounded faster (11.5% CAGR vs 0.3%).

CVD Equipment Corp designs, manufactures and supplies custom chemical vapor deposition systems, thermal processing equipment and related process control solutions. Its offerings cater to semiconductor manufacturing, renewable energy, aerospace, and advanced materials research segments, serving commercial and academic customers globally.

Retractable Technologies Inc is a specialized medical device manufacturer that designs, manufactures and distributes safety-engineered disposable medical products, including retractable syringes, safety needles and IV catheters. Its key customers are healthcare facilities, pharmaceutical companies and public health agencies across North America and global markets, helping reduce needlestick injury risks for medical personnel and patients.

CVV vs RVP — Head-to-Head

Bigger by revenue
RVP
RVP
1.9× larger
RVP
$9.4M
$5.0M
CVV
Growing faster (revenue YoY)
RVP
RVP
+37.3% gap
RVP
4.0%
-33.2%
CVV
Higher net margin
RVP
RVP
0.7% more per $
RVP
-24.9%
-25.6%
CVV
Faster 2-yr revenue CAGR
RVP
RVP
Annualised
RVP
11.5%
0.3%
CVV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CVV
CVV
RVP
RVP
Revenue
$5.0M
$9.4M
Net Profit
$-1.3M
$-2.3M
Gross Margin
22.2%
-16.2%
Operating Margin
-27.2%
-81.7%
Net Margin
-25.6%
-24.9%
Revenue YoY
-33.2%
4.0%
Net Profit YoY
-1060.6%
-162.3%
EPS (diluted)
$-0.19
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CVV
CVV
RVP
RVP
Q4 25
$5.0M
$9.4M
Q3 25
$7.4M
$10.1M
Q2 25
$5.1M
$10.4M
Q1 25
$8.3M
$8.3M
Q4 24
$7.4M
$9.1M
Q3 24
$8.2M
$10.3M
Q2 24
$6.3M
$6.0M
Q1 24
$4.9M
$7.6M
Net Profit
CVV
CVV
RVP
RVP
Q4 25
$-1.3M
$-2.3M
Q3 25
$384.0K
$371.0K
Q2 25
$-1.1M
$-87.5K
Q1 25
$360.0K
$-10.5M
Q4 24
$132.0K
$3.8M
Q3 24
$203.0K
$-1.9M
Q2 24
$-761.0K
$-14.2M
Q1 24
$-1.5M
$429.4K
Gross Margin
CVV
CVV
RVP
RVP
Q4 25
22.2%
-16.2%
Q3 25
32.7%
16.7%
Q2 25
21.0%
-1.0%
Q1 25
32.4%
-0.0%
Q4 24
26.3%
-27.5%
Q3 24
21.5%
-0.1%
Q2 24
24.3%
-7.0%
Q1 24
16.2%
25.0%
Operating Margin
CVV
CVV
RVP
RVP
Q4 25
-27.2%
-81.7%
Q3 25
4.2%
-36.2%
Q2 25
-22.3%
-49.1%
Q1 25
3.2%
-56.4%
Q4 24
0.4%
-79.6%
Q3 24
0.9%
-49.6%
Q2 24
-14.2%
-95.6%
Q1 24
-33.0%
-39.3%
Net Margin
CVV
CVV
RVP
RVP
Q4 25
-25.6%
-24.9%
Q3 25
5.2%
3.7%
Q2 25
-20.8%
-0.8%
Q1 25
4.3%
-126.6%
Q4 24
1.8%
41.6%
Q3 24
2.5%
-18.6%
Q2 24
-12.0%
-234.9%
Q1 24
-29.9%
5.7%
EPS (diluted)
CVV
CVV
RVP
RVP
Q4 25
$-0.19
$-0.09
Q3 25
$0.06
$0.01
Q2 25
$-0.15
$0.00
Q1 25
$0.05
$-0.35
Q4 24
$0.02
$0.14
Q3 24
$0.03
$-0.07
Q2 24
$-0.11
$-0.48
Q1 24
$-0.22
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CVV
CVV
RVP
RVP
Cash + ST InvestmentsLiquidity on hand
$8.7M
$2.6M
Total DebtLower is stronger
$895.6K
Stockholders' EquityBook value
$24.7M
$74.4M
Total Assets
$27.5M
$142.6M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CVV
CVV
RVP
RVP
Q4 25
$8.7M
$2.6M
Q3 25
$8.4M
$3.4M
Q2 25
$7.0M
$3.0M
Q1 25
$10.2M
$3.4M
Q4 24
$12.6M
$4.2M
Q3 24
$10.0M
$3.9M
Q2 24
$10.0M
$6.9M
Q1 24
$11.9M
$10.0M
Total Debt
CVV
CVV
RVP
RVP
Q4 25
$895.6K
Q3 25
Q2 25
Q1 25
Q4 24
$268.0K
$1.2M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CVV
CVV
RVP
RVP
Q4 25
$24.7M
$74.4M
Q3 25
$25.8M
$76.8M
Q2 25
$25.2M
$76.5M
Q1 25
$26.0M
$76.6M
Q4 24
$25.4M
$87.2M
Q3 24
$25.0M
$83.5M
Q2 24
$24.5M
$85.4M
Q1 24
$25.0M
$99.7M
Total Assets
CVV
CVV
RVP
RVP
Q4 25
$27.5M
$142.6M
Q3 25
$29.8M
$146.4M
Q2 25
$29.9M
$147.1M
Q1 25
$31.1M
$149.3M
Q4 24
$31.7M
$160.7M
Q3 24
$31.8M
$157.8M
Q2 24
$33.8M
$160.7M
Q1 24
$35.4M
$176.0M
Debt / Equity
CVV
CVV
RVP
RVP
Q4 25
0.01×
Q3 25
Q2 25
Q1 25
Q4 24
0.01×
0.01×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CVV
CVV
RVP
RVP
Operating Cash FlowLast quarter
$397.0K
$-596.5K
Free Cash FlowOCF − Capex
$396.0K
FCF MarginFCF / Revenue
8.0%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CVV
CVV
RVP
RVP
Q4 25
$397.0K
$-596.5K
Q3 25
$1.4M
$-1.3M
Q2 25
$-3.2M
$-3.7M
Q1 25
$-2.3M
$-1.5M
Q4 24
$2.3M
$-1.1M
Q3 24
$32.0K
$-5.7M
Q2 24
$-1.7M
$-2.7M
Q1 24
$-2.0M
$-2.0M
Free Cash Flow
CVV
CVV
RVP
RVP
Q4 25
$396.0K
Q3 25
$-1.3M
Q2 25
$-3.2M
$-4.1M
Q1 25
$-2.3M
$-1.6M
Q4 24
$2.1M
$-1.4M
Q3 24
$-5.0K
$-6.5M
Q2 24
$-1.8M
$-2.8M
Q1 24
$-2.1M
$-2.2M
FCF Margin
CVV
CVV
RVP
RVP
Q4 25
8.0%
Q3 25
-13.4%
Q2 25
-62.1%
-38.9%
Q1 25
-27.7%
-18.8%
Q4 24
28.8%
-15.5%
Q3 24
-0.1%
-63.0%
Q2 24
-29.0%
-46.8%
Q1 24
-42.9%
-29.6%
Capex Intensity
CVV
CVV
RVP
RVP
Q4 25
0.0%
Q3 25
0.0%
0.9%
Q2 25
0.1%
3.2%
Q1 25
0.5%
1.0%
Q4 24
1.5%
3.3%
Q3 24
0.5%
7.7%
Q2 24
1.8%
2.0%
Q1 24
1.4%
3.0%
Cash Conversion
CVV
CVV
RVP
RVP
Q4 25
Q3 25
3.53×
-3.39×
Q2 25
Q1 25
-6.28×
Q4 24
17.05×
-0.29×
Q3 24
0.16×
Q2 24
Q1 24
-4.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CVV
CVV

Transferred Over Time$3.8M76%
Transferred At Point In Time$1.2M24%

RVP
RVP

Segment breakdown not available.

Related Comparisons